Digest Network Come funziona
Network
/
Società
Ar
Non verificato

Arrowhead Pharmaceuticals, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieSaluteScienza

90 comunicati stampa

Guarda tutti i comunicati
04/08/2026
Web e Social Network
Telefonia e Varie
Eventi
Mercato azionario
Cardiologia
Biotecnologia
Farmaceutica
Salute
Igiene alimentare
Medicina - Varie
Arrowhead Pharmaceuticals Reports Fiscal 2026 Third Quarter Results
Fonte
Arrowhead Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
04/08/2026
Biotecnologia
Igiene alimentare
Salute
Farmaceutica
Medicina - Varie
Arrowhead Pharmaceuticals Acquires FDA Priority Review Voucher
Fonte
Arrowhead Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
03/08/2026
Mercato azionario
Finanza
Salute
Biotecnologia
Medicina - Varie
Scienza
Farmaceutica
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Fonte
Arrowhead Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
22/07/2026
Web e Social Network
Telefonia e Varie
Eventi
Industria
Scienza
Cardiologia
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Arrowhead Pharmaceuticals Reports Topline Results from Phase 3 SHASTA-3 and SHASTA-4 Studies of Plozasiran in Patients with Severe Hypertriglyceridemia
Fonte
Arrowhead Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
21/07/2026
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Salute
Biotecnologia
Medicina - Varie
Scienza
Farmaceutica
Arrowhead Pharmaceuticals to Webcast Fiscal 2026 Third Quarter Results
Fonte
Arrowhead Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
22/06/2026
Industria
Scienza
Sanità
Farmaceutica
Oncologia
HIV, AIDS e malattie autoimmuni
Biotecnologia
Medicina - Varie
Igiene alimentare
Salute
Arrowhead Pharmaceuticals Receives Marketing Authorization in the European Union for REDEMPLO® (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS)
Fonte
Arrowhead Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
18/06/2026
Web e Social Network
Scienza
Biotecnologia
Salute
Medicina - Varie
Cardiologia
Sanità
Farmaceutica
Arrowhead Pharmaceuticals to Host a Webinar on its Cardiometabolic Pipeline as Part I of the 2026 Summer Series of R&D Webinars
Fonte
Arrowhead Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
02/06/2026
Eventi
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Arrowhead Pharmaceuticals to Participate in Upcoming June 2026 Events
Fonte
Arrowhead Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
27/05/2026
Scienza
Salute
Biotecnologia
Medicina - Varie
Sanità
Farmaceutica
Eventi
Industria
Arrowhead Pharmaceuticals Presents New Clinical Data on RNAi-based Obesity and MASH Candidate ARO-INHBE at EASL 2026
Fonte
Arrowhead Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
26/05/2026
Web e Social Network
Eventi
Industria
Salute
Biotecnologia
Medicina - Varie
Farmaceutica
Cardiologia
Arrowhead Pharmaceuticals Presents New Positive Clinical Cardiometabolic Data at the 94th European Atherosclerosis Society (EAS) Congress
Fonte
Arrowhead Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0